SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Adline Chem Lab - Quaterly Results

15 Jul 2024 Evaluate
Revenue showed a marginal decline at Rs. 0.00 millions. For the quarter ended June 2024, as compared to corresponding quarter of last year.The Net Loss for the quarter ended June 2024 is Rs. -1.02 millions as compared to Net Loss of Rs. -0.82 millions of corresponding quarter ended June 2023 Operating profit Margin for the quarter ended June 2024 further decreased to -1.02% as compared to -0.82% of corresponding quarter ended June 2023


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.31 9.95 -96.88
PBIDT -1.02 -0.82 24.39 -1.02 -0.82 24.39 -1.46 1.99 -173.37
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT -1.02 -0.82 24.39 -1.02 -0.82 24.39 -1.46 -41.46 -96.48
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.88 0.00
PBT -1.02 -0.82 24.39 -1.02 -0.82 24.39 -1.46 -42.34 -96.55
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -1.02 -0.82 24.39 -1.02 -0.82 24.39 -1.47 -42.34 -96.53
Equity 58.50 58.50 0.00 58.50 58.50 0.00 58.50 58.50 0.00
PBIDTM(%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Adline Chem Lab Share Price

11.28 0.00 (0.00%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1679.85
Dr. Reddys Lab 1333.05
Cipla 1305.85
Zydus Lifesciences 947.10
Lupin 2340.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×